Compare Mutual Funds

Pros

-

5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Among most bought funds within the category.

Among most bought funds within the category.

Cons

-

-

INDMoney rank
-
2/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

1 Years 3 Months

7 Years 9 Months

Fund AUM

₹315 Cr

₹6801 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹500
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.74%

1.04%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

39

43

Top 5 Holdings
  1. Divi's Laboratories Ltd(9.21%)
  2. Sun Pharmaceuticals Industries Ltd(8.4%)
  3. Apollo Hospitals Enterprise Ltd(6.8%)
  4. Piramal Pharma Ltd(6.21%)
  5. Aurobindo Pharma Ltd(5.93%)
  1. Sun Pharmaceuticals Industries Ltd(11.21%)
  2. Cipla Ltd(9.4%)
  3. Mankind Pharma Ltd(7.64%)
  4. Dr Reddy's Laboratories Ltd(6.52%)
  5. Biocon Ltd(6.2%)
No of Sectors

5

2

Top 3 Sectors
  1. Health(89.06%)
  2. Corporate(27.34%)
  3. Government(8.66%)
  1. Health(98.81%)
  2. Basic Materials(1.19%)
Equity %

97.53%

97.98%

Debt %

0.35%

-

P/E

43.5

32.15

P/B

5.76

3.94

Credit Quality

-

-

Modified Duration

0.44

-

YTM

6.39

-

1-Month Return

-2.89%

-2.65%

3-Month Return

-4.13%

-5.65%

6-Month Return

-3.59%

-5.41%

1-Year Return

3.1%

3.14%

3-Year Return

-

28.2%

5-Year Return

-

18.5%

Sharpe

-

1.3

Alpha

-

2.27

Beta

-

0.94

Standard Deviation

-

15.86

Information Ratio

-

0.44

Description

Bajaj Finserv Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Sorbh Gupta, Nimesh Chandan, Siddharth Chaudhary

Dharmesh Kakkad, Sharmila D’mello

Most Popular Comparisons